1. Home
  2. APRE vs ABTS Comparison

APRE vs ABTS Comparison

Compare APRE & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • ABTS
  • Stock Information
  • Founded
  • APRE 2006
  • ABTS 2010
  • Country
  • APRE United States
  • ABTS Hong Kong
  • Employees
  • APRE N/A
  • ABTS N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • ABTS Computer Software: Programming Data Processing
  • Sector
  • APRE Health Care
  • ABTS Technology
  • Exchange
  • APRE Nasdaq
  • ABTS Nasdaq
  • Market Cap
  • APRE 13.5M
  • ABTS 15.9M
  • IPO Year
  • APRE 2019
  • ABTS N/A
  • Fundamental
  • Price
  • APRE $1.80
  • ABTS $2.05
  • Analyst Decision
  • APRE Strong Buy
  • ABTS
  • Analyst Count
  • APRE 2
  • ABTS 0
  • Target Price
  • APRE $15.50
  • ABTS N/A
  • AVG Volume (30 Days)
  • APRE 21.0K
  • ABTS 21.7K
  • Earning Date
  • APRE 05-13-2025
  • ABTS 12-31-2024
  • Dividend Yield
  • APRE N/A
  • ABTS N/A
  • EPS Growth
  • APRE N/A
  • ABTS N/A
  • EPS
  • APRE N/A
  • ABTS N/A
  • Revenue
  • APRE $1,502,581.00
  • ABTS $5,343,888.00
  • Revenue This Year
  • APRE N/A
  • ABTS N/A
  • Revenue Next Year
  • APRE N/A
  • ABTS N/A
  • P/E Ratio
  • APRE N/A
  • ABTS N/A
  • Revenue Growth
  • APRE 157.63
  • ABTS 3970.66
  • 52 Week Low
  • APRE $1.85
  • ABTS $0.25
  • 52 Week High
  • APRE $6.70
  • ABTS $4.19
  • Technical
  • Relative Strength Index (RSI)
  • APRE 26.70
  • ABTS 46.08
  • Support Level
  • APRE $1.85
  • ABTS $2.92
  • Resistance Level
  • APRE $2.30
  • ABTS $3.28
  • Average True Range (ATR)
  • APRE 0.16
  • ABTS 0.26
  • MACD
  • APRE -0.01
  • ABTS -0.21
  • Stochastic Oscillator
  • APRE 2.50
  • ABTS 0.00

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About ABTS Abits Group Inc

Abits Group Inc is a digital data center operator with bitcoin self-mining operations.

Share on Social Networks: